Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
STTK
STTK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
STTK News
Shattuck Labs to Participate in Immunology Symposium
Feb 06 2026
Newsfilter
Shattuck Labs Shares Rise After Piper Sandler Initiates Overweight Rating
Jan 28 2026
seekingalpha
Latest Rating Changes on Wall Street
Jan 28 2026
CNBC
Shattuck Labs (STTK) Stock Soars 74% Following Analyst Upgrade to Buy
Jan 06 2026
Fool
Shattuck Labs Upgraded to Buy by Analyst, Stock Surges 74%
Jan 06 2026
NASDAQ.COM
Shattuck Labs Upgraded to Buy by Analyst, Stock Soars 74%
Jan 06 2026
Yahoo Finance
Shattuck Labs Grants 206,000 Stock Options to Attract New Executive
Dec 15 2025
Globenewswire
Shattuck Labs (STTK) Price Target Raised by 33.33% to $4.08
Dec 06 2025
NASDAQ.COM
Analyst Upgrade Enhances Confidence in Shattuck's Next-Gen Inflammatory Bowel Disease Treatment
Dec 01 2025
Benzinga
Shattuck Labs to Attend Investor Conferences Scheduled for December
Nov 20 2025
Newsfilter
Shattuck Labs to Take Part in Upcoming Wedbush Securities Key Opinion Leader and Company Panel
Oct 02 2025
Newsfilter
Shattuck Labs (STTK) Receives Upgrade to Buy: Implications for the Stock
Sep 08 2025
NASDAQ.COM
Shattuck Labs Confirms IND Approval for SL-325 to Treat Inflammatory Bowel Disease
Aug 21 2025
Newsfilter
Leerink Partners Maintains Outperform on Shattuck Labs, Lowers Price Target to $2
Aug 14 2025
Benzinga
Needham Reiterates Hold on Shattuck Labsto Hold
Aug 14 2025
Benzinga
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
Aug 05 2025
TipRanks
Show More News
